Article Versions Notes

Vincent TS, Zhu M, Parekh A, Patel U, Cloney-Clark S, Klindworth A, Silva D, Gorinson A, Miranda K, Wang M, et al. A Modified Novel Validated High-Throughput Hemagglutinin Inhibition Assay Using Recombinant Virus-like Particles and Human Red Blood Cells for the Objective Evaluation of Recombinant Hemagglutinin Nanoparticle Seasonal Influenza Vaccine. Microorganisms. 2024; 12(11):2358. https://doi.org/10.3390/microorganisms12112358

Vincent, Timothy S., Mingzhu Zhu, Anand Parekh, Urvashi Patel, Shane Cloney-Clark, Andrew Klindworth, David Silva, Andrew Gorinson, Karlee Miranda, Mi Wang, and et al. 2024. "A Modified Novel Validated High-Throughput Hemagglutinin Inhibition Assay Using Recombinant Virus-like Particles and Human Red Blood Cells for the Objective Evaluation of Recombinant Hemagglutinin Nanoparticle Seasonal Influenza Vaccine" Microorganisms 12, no. 11: 2358. https://doi.org/10.3390/microorganisms12112358

Vincent, T. S., Zhu, M., Parekh, A., Patel, U., Cloney-Clark, S., Klindworth, A., Silva, D., Gorinson, A., Miranda, K., Wang, M., Longacre, Z., Zhou, B., Cho, I., Cai, R., Kalkeri, R., Fries, L., Shinde, V., & Plested, J. S. (2024). A Modified Novel Validated High-Throughput Hemagglutinin Inhibition Assay Using Recombinant Virus-like Particles and Human Red Blood Cells for the Objective Evaluation of Recombinant Hemagglutinin Nanoparticle Seasonal Influenza Vaccine. Microorganisms, 12(11), 2358. https://doi.org/10.3390/microorganisms12112358